The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MEVITEM: A European, randomized, open-label Phase I/II of vismodegib in combination with temozolomide versus temozolomide alone in adult patients with recurrent/ refractory medulloblastoma presenting an activation of the Sonic Hedgehog pathway.
 
Didier Frappaz
No Relationships to Disclose
 
Olivier L. Chinot
No Relationships to Disclose
 
David Meyronet
No Relationships to Disclose
 
Gwenaelle Garin
No Relationships to Disclose
 
Florence Laigle-Donadey
No Relationships to Disclose
 
Emilie Le Rhun
No Relationships to Disclose
 
Alice bonneville - Levard
No Relationships to Disclose
 
Jean-Sebastien Frenel
No Relationships to Disclose
 
Ahmed Idbaih
No Relationships to Disclose
 
Carole Gourmelon
No Relationships to Disclose
 
Krisztian Homisco
No Relationships to Disclose
 
Andreas Hottinger
No Relationships to Disclose
 
Emilie Remir
No Relationships to Disclose
 
Laure Jaouen
No Relationships to Disclose
 
Carole Arbault
No Relationships to Disclose
 
Claire Cropet
No Relationships to Disclose
 
David Pérol
No Relationships to Disclose